Vincent J Gnanapragasam (Prof)

Professor of Urology & Honorary Consultant Urologist

University of Cambridge & Cambridge University Hospital NHS Trust, UK

Latest Contribution

Does empowering men on active surveillance for prostate cancer improve patient compliance and reduce conversion to treatment?

4 November 2025 | | URO - Core Urology, URO - Urologic Oncology

Active surveillance is a major treatment option for patients with favourable prognosis prostate cancer, such as those regarded as Cambridge Prognostic Group (CPG) 1 and 2 [1]. The rationale for this management strategy is the lack of survival benefit from...

Map showing countries that have accessed PREDICT Prostate

PREDICT Prostate – individualised, evidence-based estimates of survival and treatment benefit

5 November 2019 | | URO - Urologic Oncology, URO - Technology

Earlier this year ‘PREDICT Prostate’ was launched online alongside a high-profile publication in PLOS Medicine. The prognostic model and decision-aid has been designed to inform treatment decision-making among men newly diagnosed with non-metastatic prostate cancer. David Thurtle and Vincent Gnanapragasam...